Adalimumab serum levels and anti-drug antibodies: associations to treatment response and drug survival in inflammatory joint diseases. - Jyssum I; Gehin JE; Sexton J; Kristianslund EK; Hu Y; Warren DJ; Kvien TK; Haavardsholm EA; Syversen SW; Bolstad N; Goll GL (Rheumatology (Oxford, England), 2024)